Flex Pharma Appoints Kathie Lindemann Chief Operating Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Flex Pharma (FLKS) Appoints New COO
September 9, 2015 10:18 AM EDTFlex Pharma (NASDAQ: FLKS) announced the appointment of Kathie Lindemann as its Chief Operating Officer, reporting to Christoph Westphal M.D., Ph.D., Flex Pharmas President, CEO and Chair.
Prior to joining Flex Pharma, Ms. Lindemann served as Chief Operating Officer at DAVIDs TEA Inc (NYSE: DTEA). Ms.... More
